Abstract

Aim Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). Methods In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD. Results The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m2. The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. Conclusion To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables.

Highlights

  • According to data, about 25% of all cancers are in the gastrointestinal tract (GIT), making it the dominant cancer affected site [1]

  • Women were more represented (54% vs. 46%). e mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m2, while the mean WC was 105.51 ± 14.56 cm. e prevalence of Nonalcoholic fatty liver disease (NAFLD) based on transient elastography (TE)-controlled attenuation parameter (CAP) was 82.6% (774/937)

  • Similar results of higher prevalence in patients with elevated CAP were observed with Gastroesophageal reflux disease (GERD), hiatal hernia, and insufficient cardia

Read more

Summary

Introduction

About 25% of all cancers are in the gastrointestinal tract (GIT), making it the dominant cancer affected site [1]. As it is the case with most human tumors, esophageal carcinoma (EAC) is preceded by premalignant lesion or Barrett esophagus (BE). The diagnosis of NAFLD represents a clinical challenge because most of NAFLD patients are asymptomatic It is not the optimal method, liver biopsy (LB) is still the gold standard for the diagnosis and staging of NAFLD. According to a recent study, CAP and LSM are good noninvasive methods for the assessment of steatosis and fibrosis in patients with NAFLD [16]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call